IDYA Reports $15.2M Revenue, $0.08 EPS, +112% YoY, Announces $58% PFS Improvement, 37.1% ORR, 6.9-Month PFS, NDA Target 2H2026
IDEAYA Biosciences, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $28.94
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS